Mumbai, Nov. 6 -- Zydus Lifesciences Ltd reported double-digit revenue and profit growth on Thursday, beating expectations for the September quarter.

The Ahmedabad-based drugmaker's consolidated revenue from operations grew 17% year-on-year to Rs.6,123.2 crore, while net profit grew 38% on-year to Rs.1,258.6 crore.

A Bloomberg poll had pegged revenue at Rs.5,953 crore and net profit at Rs.1,088.9 crore.

Its earnings before interest, taxes, depreciation, and amortization (Ebitda) for the quarter stood at Rs.2,015.8 crore, up 38% on-year, while Ebitda margin expanded 500 basis points on-year to 32.9%.

The growth was driven by outperformance in its US and India formulations business, as well as sustained high growth in international mark...